Outsourcing Your Way Into Trouble: Pfizer Issues Recall After Aurobindo Mislabels Bottles
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer says the voluntary recall is for one lot of anti-depressant medications that may have been incorrectly labeled as benign prostatic hyperplasia treatment, or vice versa.